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Introduction. Meningococcal infection (MI) and N. meningitidis carriage are widespread. 
The global incidence represents a total of 500,000-1,200,000 cases per year, of which 
50,000-135,000 are fatal. In European countries the incidence is 0.6-2.0 per 100,000. 
Infants and young people are more likely to get affected due to different genotypes of 
meningococci. Thus, MI surveillance is required. 
Material and methods. The research purpose was to perform an epidemiological analysis 
of MI in the Republic of Moldova between 2000 and 2019. In the descriptive retrospective 
epidemiological study were analysed the total MI incidence of a population of 100,000 
people, the number of cases in urban and rural areas, the morbidity rate among 1000 
children aged between 0 and 17 years, and patients’ age structure. 
Results. A decreased incidence, without cyclicity, was registered over the past 5 years from 
2.57 to 0.55-1.01 per 100,000. The number of carriers accounted for 0.48-0.26 per 100,000 
between 2000 and 2005, and zero during 2016-2019. MI vaccination is not carried out. The 
MI incidence in urban and rural areas was the same. In children aged between 0 and 17 
years, during 2000 and 2005, MI incidence was 0.05–0.07, compared to 2016–2019 when it 
constituted 0.02–0.04 per 1000. In children aged between 0 and 2 years these indices were 
0.08 per 1000 in 2004, and 0.44 per 1000 in 2018. Thus, the indices were lower among 
children aged between 3 and 6 years. 
Conclusions. Incomplete detection of MI has been noted. Children aged between 0 and 2 
years are prone to develop MI, the most vulnerable ones being children aged up to one 
year. The age structure of patients depends on the intensity of the epidemic process. Hence, 
it is necessary to improve MI surveillance with genotyping of circulating strains. 
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PREZENTARE GENERALĂ A ASPECTELOR CARACTERISTICE ALE MORBIDITĂȚII PRIN  
INFECȚIA MENINGOCOCICĂ ÎN REPUBLICA MOLDOVA ÎN PERIOADA ANILOR 2000-2019 
Introducere. Infecția meningococică (IM) și portaj de N. meningitidis sunt larg 
răspândite, incidența globală fiind de 500.000-1.200.000 cazuri anual; 50.000-135.000 
dintre ele sunt fatale; în țările europene incidența este de 0,6-2,0 la 100.000. Cei mai 
afectați sunt sugarii, adolescenții și adulții tineri. Din cauza variațiilor genetice ale menin-
gococilor, este necesară o supraveghere permanentă a IM. 
Material și metode. Scopul lucrării - analiza epidemiologică a IM în Republica Moldova în 
aa. 2000-2019. În cadrul studiului descriptiv-retrospectiv epidemiologic au fost analizate 
morbiditatea generală prin IM la 100 mii populație, numărul de cazuri atestate în zonele 
urbane și în cele rurale, rata morbidității, înregistrate pe un eșantion de 1000 de copii, 
având vârsta de 0-17 ani și structura de vârstă a bolnavilor. 
Rezultate. Este evidentă diminuarea aciclică a morbidității, de la 2,57 la 100 mii popu-
lație, până la 0,55-1,01 în ultimii 5 ani. Numărul purtătorilor în 2000-2005 era 0,48-0,26 
la 100 mii, și zero în 2016-2019. Vaccinarea împotriva IM nu se realizează. Intensitatea IM 
în zonele urbane și în cele rurale este la același nivel. La copiii de 0-17 ani, IM era de 0,05-
0,07 în 2000-2005 și de 0,02-0,04 la 1000 copii în 2016-2019; la cei de 0-2 ani era de la 
0,44 în 2004 și de la 0,08 la 1000 în 2018. La copiii de 3-6 ani este o incidență mai joasă. 
Concluzii. Se constată evidențierea incompletă a IM. Cei mai afectați sunt copiii de 0-2 ani, 
în special cei de până la un an. Structura de vârstă a bolnavilor depinde de intensitatea 
proceslui epidemic. Se impune perfecționarea sistemului de supraveghere a IM cu genoti-
parea tulpinilor circulante. 
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INTRODUCTION 
Meningococcal infection (MI) caused by Neisseria 
meningitidis bacterium, at least 13 genotypes, as 
well as the asymptomatic carriage of the causa-
tive agent, are widespread throughout the world. 
The distribution of meningococcal serogroups 
varies according to world regions (1-4). The 
overall incidence of invasive meningococcal dis-
ease varies between 500,000 and 1,200,000 cas-
es each year; of which, from 50,000 to 135,000 
cases are fatal (5). In the European countries, the 
overall MI notification rate is from 0.6 to 2.0 per 
100,000 people and varies in different regions. 
For example, in 2016, 3280 confirmed cases of 
invasive meningococcal disease, including 304 
deaths, were reported in 30 EU Member States. 
In some countries the epidemiological situation 
of MI is quite dramatic, such as the tenfold in-
crease in MenW type IM in the United Kingdom, 
recorded between 2009-2010 – 2016-2017 (6). 
Serogroups B and C are the most common causes 
of MI in Europe, but an increase in serogroup W 
has been observed in recent years. Generally, 
serogroup B causes the highest burden in Eu-
rope, followed by serogroups C, W and Y (1, 7).  
Nasopharyngeal colonization with Neisseria me-
ningitidis ranges from 5-10% to 25% in certain 
populations (the highest is found in adolescents 
and closed groups). Invasive meningococcal di-
sease is a major cause of meningitis and septi-
cemia. It often has a rapid evolution, with a ratio 
of 8-15% case-fatality. Some age groups are dis-
proportionately affected by MI, with major inci-
dence peaks occurring in infants, adolescents, 
and young adults (1, 2, 3, 8). 
In recent years within the Global Meningococcal 
Initiative (GMI), the global importance of menin-
gococcal disease, the ever-changing epidemio-
logy, and the importance of proper surveillance 
of this evidence-based disease have been em-
phasized. Due to large geographical variations of 
circulating meningococcal serogroups, each 
country should be further monitored in order to 
change major disease-causing serogroups, as 
well as to spread information on vaccination and 
control policies. Likewise, the laboratory capaci-
ty must be properly adapted to better under-
stand local epidemiology and disease burden, as 
well as its impact (9-12). 
Inactivated meningococcal vaccines are author-
ized. There are conjugate polysaccharide and po- 
 
 
lysaccharide vaccines containing capsules of 
serotypes A, C, Y and W. Antibiotics are used to 
eliminate infection transmission and to treat the 
disease (1, 2, 3).  
It can be concluded that analysis of epidemiolog-
ical data on MI in different regions is necessary 
and relevant for a multilateral assessment. Such 
analyses have not been performed, which makes 
prevention difficult. The ongoing surveillance of 
MI is important for the development of future 
vaccination and surveillance policies.  
 
MATERIAL AND METHODS 
The purpose of the research is to analyze the epi-
demiological data collected in the Republic of 
Moldova over a period of about 20 years (2000-
2019) in order to estimate the incidence and 
characteristics of meningococcal infection. In 
order to reveal the problems related to menin-
gococcal infection worldwide, 212 bibliographic 
sources were analyzed as well as the WHO, CDC, 
ECDC materials published in the last five years.  
The analysis of meningococcal infection morbi-
dity in the Republic of Moldova over the period 
2000-2019 was performed in the descriptive re-
trospective epidemiological study based on offi-
cial statistical data (F.2) with the presentation of 
intensive and extensive indices, such as general 
morbidity per 100 thousand people (popula-
tion), number of cases in urban and rural areas, 
morbidity of children aged 0-17 years by age 
groups per 1000 children, age structure of pa-
tients (%), including adults, children up to one 
year, 0-2; 3-6; 7-17 years. There were analyzed 
MI cases of 71 patients hospitalized over the 
period 2010-2019 in the Municipal Clinical Chil-
dren’s Hospital of Infectious Diseases.  
 
RESULTS 
The statistical data on the spread of meningococ-
cal infection in the Republic of Moldova before 
2000, revealed that between 1945 and1969 the 
morbidity on average was recorded at 0.98 cases 
per 100,000 people, between 1970 and 1989 it 
considerably increased (220-230 times com-
pared to 1963). Over the period 1990-1999, 2-4 
cases per 100,000 people were registered (13, 
14). Vaccination against meningococcal infection 
is neither included in the National Immunization 
Program, nor carried out. 
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Figure 1. Data on the evolution of meningococcal infection morbidity  
and the level of N. meningitidis carriage, Republic of Moldova, 2000-2019. 
 
Analysis of morbidity indices of meningococcal 
infection during the reference period found 
(fig.1) a gradual decrease from 2.57 to 100 thou-
sand people (111 cases) at the beginning of the 
period, up to 0.55-1.01 over the last 5 years (on 
average 23.6 cases per year). Analysis of multi-
annual morbidity of meningococcal infection did 
not highlight any cyclicity. The number of N. 
meningitidis carriers over the period 2000-2005 
accounted for 0.48-0.26 per 100 thousand peo-
ple (14.5 cases on average annually), then sud-
denly decreased to 0 (zero) during 2016-2019. 
 
 
 
Figure 2. Data on the number of cases of meningococcal infection in urban and rural areas,  
Republic of Moldova, 2000-2019. 
 
The data presented in Figure 2 show that the 
ratio of the number of cases of meningococcal 
infection in rural and urban areas ranges be-
tween 0 and 8 (2015 and 2018). The average 
annual ratio of cases of meningococcal infection 
in rural and urban areas is equal to 2.54, which 
broadly reflects the ratio of the population in 
these two regions. 
 
In order to take adequate surveillance and con-
trol measures of meningococcal infection, it is 
important to analyze how frequently and inten-
sively different age groups of the population are 
affected, considering the fact that according to 
multiple scientific publications a higher inci-
dence is observed in infants, adolescents, and 
young adults (1, 2, 3, 8, 13). The data recorded in  
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the  Republic  of  Moldova  during  the  reference period are presented in Figure 3. 
 
 
 
Figure 3. Data on meningococcal infection morbidity in children of different ages,  
Republic of Moldova, 2000-2019. 
 
Data presented in Fig. 3 show that the morbidity 
of meningococcal infection in children aged be-
tween 0 and 17 years was 0.05-0.07 per 1000 
children over the period 2000-2005 and 0.02-
0.04 per 1000 children over the period 2016-
2019. The morbidity level in children aged be-
tween 0 and 2 years ranged from 0.44 to 1000 
children in 2004 and 0.08 to 1000 children in 
2018. In children aged 3-6 years there was a 
lower incidence, 0.01 per 1000 children over the 
period 2017-2019 and 0.1 per 1000 children in 
2005. 
 
Table 1. Age distribution of MI patients in the Republic of Moldova, 2000-2019. 
 
 
Age structure analysis of patients with meningo-
coccal infection (tab. 1) shows that among the 
total number of patients the disease predomi-
nated in children 72.6-94.4%, in different peri-
ods. The rate of children aged between 0 and 2 
years was the highest compared to other age 
groups, being within 43.3% in the first period 
and 94.4% during 2010-2014. Particular atten-
tion was drawn to children up to one year that 
constituted a rather large number among pa-
tients with meningococcal infection; the rate 
ranged from 17.9% in the first period and 32.2% 
in the last one. The epidemic incidence, with ex-
pressed intensity, was higher among adult pa-
tients,  27.4%  during  2000-2004,  compared  to  
 
 
 
5.6%-9.7% in other researched periods. 
During 2010-2019, in the Municipal Clinical 
Children’s Hospital of Infectious Diseases in Chis-
inau, 71 patients with meningococcal infection 
were admitted (23.3% of the total number of 
patients – 305 people). Annually, the number of 
children hospitalized with MI fluctuated, 10-16 
patients per year (44.8-71.7% of the total num-
ber of patients) during 2010-2015 and 2-4 per 
year (7.4-14.8% of the total number of patients) 
during 2016-2019. Respectively, MI share was 
0.02-0.2% per hospitalized patients. All patients 
developed meningococcemia, a severe form of 
MI; about 75% had purulent meningitis, of which 
over 2/3 of cases had toxic shock syndrome and/ 
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ber of cases 
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Average age rate of MI patients (%) per year 
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children’s age, years 
0-17 
0-2 (includ-
ing < 1 year) 
3-6 7-17 
2000-2004 430 86 27.4 72.6 43.3 (17.9) 12.1 17.3 
2005-2009 247 49.4 9.7 90.3 55.5 (20.2) 17.8 17.0 
2010-2014 177 35.4 5.6 94.4 71.7 (20.1) 14.2 8.5 
2015-2019 118 23.6 8.5 91.5 64.4 (32.2) 12.6 14.5 
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or cerebral edema. Four children died (5.6%), all 
of them being up to 1 year old. The etiological 
diagnosis in most cases was assessed according 
to clinico-epidemiological pattern. As a result, 
the bacteriological examination (CSF, blood and 
nasopharynx exudate) was negative. In 2019, in 
two cases, of the total number of 3 children with 
MI, Neisseria meningitidis DNA in CSF was de-
tected using PCR.  
 
DISCUSSIONS 
During the researched period, 2000-2019, in the 
Republic of Moldova due to the absence of MI 
vaccines there was a gradual decrease in mor-
bidity of this infection (on average 23.6 cases per 
year) without obvious cyclicity. The number of N. 
meningitidis carriers dropped to 0 (zero) in the 
last three years. It is known that on average 1% 
to 10% of the population are asymptomatic car-
riers of meningococci, but in epidemic situations 
this rate ranges between 10% and 25% (1, 14). 
This accounts for the incomplete recording of 
Neisseria meningitides cases and its carriers. In  
addition, it is known that different age groups 
are disproportionately affected by MI, with ma-
jor incidence peaks occurring in infants, adoles-
cents and young adults (1, 2, 3, 8). In the Repub-
lic of Moldova, according to the analysed data, 
there is only one, so-called epidemic peak, in 
children aged between 0 and 2 years, except for 
adolescents and young adults. 
It should be noted that IM surveillance is neces-
sary to reduce the impact of meningococcal di-
sease, monitor morbidity incidence and prevent 
epidemics. This practice should include detec-
tion, application of evidence-based measures, 
and etiological investigation of each suspected 
case of meningococcal disease. In addition, mod-
ern surveillance includes the identification of 
circulating serogroups of N. meningitidis, this 
being the first step in implementing strategies to 
prevent MI by vaccination (1-3). These principles 
formulated by WHO and Global Meningococcal 
Initiative specialists should be laid on the organ-
ization of meningococcal infection surveillance 
in the Republic of Moldova. 
 
CONCLUSIONS 
1. Based on the data analysis related to morbidity of meningococcal infection and the number of N. me-
ningitidis carriers, an incomplete highlighting of the affected persons was found. 
2. Children aged between 0 and 2 years, especially infants up to one year, are most affected by menin-
gococcal infection. 
3. The age structure of patients with meningococcal infection depends on the epidemic process inten-
sity. Thus, due to progressive involvement, there might occur a higher morbidity rate among ado-
lescents and adults. 
4. In the Republic of Moldova, it is necessary to improve the surveillance and control of meningococcal 
infection as well as to carry out the permanent examination of circulating N. meningitides strains, 
including genotyping. 
 
CONFLICT OF INTERESTS 
No conflicts of interest were reported. 
 
REFERENCES  
1. ECDC. Factsheet about meningococcal disease. 
Available from: https://www.ecdc.europa.eu/ 
en/meningococcal-disease/factsheet [Accessed 
2th March 2020]. 
2. Borrow R, Alarcón P, Carlos J, et al. The Global 
Meningococcal Initiative: global epidemiology, the 
impact of vaccines on meningococcal disease and 
the importance of herd protection. Expert Rev Vac-
cines. 2017;16(4):313-328. 
3. Acevedo R, Bai X, Borrow R, et al. The Global Me-
ningococcal Initiative meeting on prevention of 
meningococcal disease worldwide: Epidemiology, 
surveillance, hypervirulent strains, antibiotic re-
sistance and high-risk populations. Expert Rev 
Vaccines. 2019;18(1):15-30. 
4. Caugant DA, Brynildsrud OB. Neisseria meningiti-
dis: using genomics to understand diversity, evo-
lution and pathogenesis. Nat Rev Microbiol. 
2020;18(2):84-96. 
5. Hennadii M. Multiple Linear Regression Model of 
Meningococcal Disease in Ukraine: 1992–2015. 
Comput Math Methods Med. 2020;20:510-512. 
doi:10.1155/2020/5105120 
6. Laboratory confirmed cases of IMD England data 
tables 2017 to 2018. Available from: 
https://assets.publishing.service.gov.uk/governm
ent/uploads/system/uploads/attachment_data/fil
e/752085/ [Accessed 2th March 2020]. 
 
 
 
22  
 
VOL. 2, ISSUE 2 
2020 
 
7. Krone M, Gray S, Abad R, et al. Increase of invasive 
meningococcal serogroup W disease in Europe, 
2013 to 2017. Euro Surveill. 2019;24(14). 
8. Presa J, Findlow J, Vojicic J, Williams S, Serra L. 
Epidemiologic Trends, Global Shifts in Meningo-
coccal Vaccination Guidelines, and Data Support-
ing the Use of MenACWY-TT Vaccine. A ReInfect 
Dis Ther. 2019;8(3):307-333. doi: 10.1007/ 
s40121-019-0254-1 
9. Purmohamad A, Abasi E, Azimi T, et al. Global es-
timate of Neisseria meningitidis serogroups pro-
portion in invasive meningococcal disease: A sys-
tematic review and meta-analysis. Microb Pathog. 
2019;134:103571. 
10. Heidi M. Soeters, Lucy A. McNamara, Amy E. Blain, 
et al. University-Based Outbreaks of Meningococ-
cal Disease Caused by Serogroup B, United States, 
2013–2018. Emerg Infect Dis. 2019;25(3):434-
440. 
11. Peterson ME, Li Y, Bita A, et al. Meningococcal 
serogroups and surveillance: a systematic review 
and survey. J Glob Health. 2019;9(1):010409. 
12. Booy R, Gentile A, Nissen M, Whelan J, Abitbol V. 
Recent changes in the epidemiology of Neisseria 
meningitidis serogroup W across the world, cur-
rent vaccination policy choices and possible future 
strategies. Hum Vaccin Immunother. 2018;15:470-
480.  
13. Rusu G, Manic L. Infecţia meningococică la copil. 
Protocol clinic naţional PCN-6 [Meningococcal in-
fection in children. National clinical protocol PCN-
6]. Chisinau, 2017.  
14. Prisacaru V. Epidemiologie speciala [Special epi-
demiology]. Chisinau, 2015. 
 
 
Date of receipt of the manuscript: 28/03/2020  
Date of acceptance for publication: 05/05/2020 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
